Loading...
•
Dec 31, 2021
CVS Health Q4 2021 Earnings Report
Reported strong Q4 and full-year results, confirming full-year EPS guidance for 2022.
Key Takeaways
CVS Health's Q4 2021 total revenues increased to $76.6 billion, up 10.1% compared to the prior year. GAAP diluted EPS was $0.98, and adjusted EPS was $1.98. The company administered over 8 million COVID-19 tests and 20 million vaccines in Q4 2021.
Total revenues increased to $76.6 billion, up 10.1% compared to prior year.
GAAP diluted EPS from continuing operations was $0.98, and Adjusted EPS was $1.98.
The company administered more than 8 million COVID-19 tests and more than 20 million COVID-19 vaccines nationwide.
CVS Health unveiled several steps to support the acceleration of the Company’s omnichannel health strategy.
Revenue by Segment
Forward Guidance
The Company confirmed its full-year 2022 GAAP diluted EPS from continuing operations guidance range of $7.04 to $7.24 and its full-year 2022 Adjusted EPS guidance range of $8.10 to $8.30. The Company also revised its full-year 2022 cash flow from operations guidance range to $12.0 billion to $13.0 billion from $12.5 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...